Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation

Experimental Hematology

Volumn 38, Issue 1, 2010, Pages 55-60

  Prébet, Thomas ^a,b   Ladaique, Patrick ^a   Ferrando, Martin ^a   Chabannon, Christian ^a   Faucher, Catherine ^a   De Lavallade, Hugues ^a   El Cheikh, Jean ^a   Furst, Sabine ^a   Vey, Norbert ^a   Stoppa, Anne Marie ^a   Viens, Patrice ^a,b   Blaise, Didier ^a,b   Mohty, Mohamad ^a,b  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN; FLUDARABINE; HLA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CONFIDENCE INTERVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SIBLING; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; WHOLE BODY RADIATION;

ADULT; AGED; BLOOD PLATELETS; BLOOD TRANSFUSION; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 71249135608     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.10.004     Document Type: Article

References (20)

1. Mohty M., Kuentz M., Michallet M., et al. Chronic graft versus host disease after allogeneic blood stem cell transplantation: long term results of a randomized study. Blood 100 (2002) 3128-3134
2. Bregni M., Dodero A., Peccatori J., et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood 99 (2002) 4234-4236
3. Holler E., Kolb H.J., Greinix H., et al. Bleeding events and mortality in SCT patients: A retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD. Bone Marrow Transplant 43 (2009) 491-497
4. Khayyata S., Soubani A.O., Bonnett M., Nassar H., Abidi M.H., and Al-Abbadi M.A. The major autopsy findings in adult patients after hematopoietic stem cell transplantation. Ann Transplant 12 (2007) 11-18
5. Storb R. Non-myeloablative preparative regimens: experimental data and clinical practice. J Clin Oncol (1998) 241-249
6. Slavin S., Nagler A., Naparstek E., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91 (1998) 756-763
7. Blaise D., Kuentz M., Fortanier C., et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 18 (2000) 537-546
8. Blaise D., Bay J.O., Faucher C., et al. Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. Blood 103 (2004) 435-441
9. Michallet M., Bilger K., Garban F., et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 19 (2001) 3340-3349
10. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
11. Faucher C., Mohty M., Vey N., et al. Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen. Exp Hematol 31 (2003) 873-880
12. Heldal D., Tjonnfjord G., Brinch L., et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 25 (2000) 1129-1136
13. Macher S., Schallmoser K., Staber P.B., et al. Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: A case report. Vox Sang 89 (2005) 257-260
14. Lee S.J., Vogelsang G., and Flowers M.E. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9 (2003) 215-233
15. Ivanov V., Faucher C., Mohty M., et al. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: Predictive value of prior Hb level. Transfusion 44 (2004) 501-508
16. French D.L., Fruchtman S., Mitchell W.B., Coller B.S., and Peretz H. Evidence for megakaryocyte engraftment following reduced-intensity conditioning. Exp Hematol 32 (2004) 877-880
17. Mohty M., Avinens O., Faucher C., Viens P., Blaise D., and Eliaou J.F. Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. Haematologica 92 (2007) 1004-1006
18. Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21 (2007) 1387-1394
19. Bussel J.B., Kuter D.J., Pullarkat V., Lyons R.M., Guo M., and Nichol J.L. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood 113 (2009) 2161-2171
20. Bussel J.B., Provan D., Shamsi T., et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: A randomised, double-blind, placebo-controlled trial. Lancet 373 (2009) 641-648